ASH 2019 logo

PlatformQ Health will present a poster session at the 2019 ASH Annual Meeting sharing insights from recent CME and patient education activities on Follicular Lymphoma December 8, 2019. In addition, the abstract will be included in their Blood journal as supplement.

The patient and clinician video-based activities were developed in collaboration with The Leukemia and Lymphoma Society. While they were unique activities with different content and audiences, they were educationally aligned in their goal to promote understanding of Follicular Lymphoma, comprehension of treatment best-practices including pathways to individualized treatment, and to improve HCP and patient communication.

“We’re thrilled to be able to share insights from this educational initiative at ASH this year,” shared Anne Roc, PhD, VP of Medical Strategy and Education at PlatformQ Health, and lead author on the poster. “This will wrap up a busy year for our team sharing insights at many Hematology & Oncology conferences, including ASCO Quality Care, ASCO, ASCO GU and ASCO GI. As we look toward 2020, we’re excited to produce more programs like this where education is purposefully aligned between patients and clinicians, and hopefully continue to disseminate their outcomes in forums like ASH and ASCO.”

Other 2019 oncology poster sessions include:

  • ASCO Quality Care 2019 – Patient Beliefs and Behaviors Concerning Clinical Trials for Blood Cancers: Outcomes from Live-Online Education
  • ASCO 2019 – Video-Based Patient Education on Carcinoid Syndrome: Positive Knowledge and Behavior Shift for Patients
  • ASCO GU 2019 – Regional Variations in Online Education Test Performance and Knowledge Retention for Prostate Cancer Care
  • ASCO GI 2019 – Improving Clinician Confidence and Practice Behavior on the Therapeutic Management of Microsatellite-Instability High (MSI-H) Gastrointestinal (GI) Cancer

Unable to attend in person, and want to learn more about how PlatformQ Health is delivering impactful education to HCPs and patients? Email us at


ASH Annual Meeting 2019

Poster Session: Sunday, December 8, 2019 6-8pm, Hall B, Level 2

Continuing Medical Education & Patient Education on Follicular Lymphoma: Changes in Clinician Practice, Patient Behaviors, and Knowledge Across Clinicians and Patients

Authors: Anne Roc, PhD, PlatformQ Health; Wendy Turell, DrPH, PlatformQ Health; Meredith Barnhart, LCSW-R, The Leukemia and Lymphoma Society; John P. Leonard, MD, Department of Medicine, Division of Hematology and Oncology, Weill Cornell Medicine, NY

BACKGROUND: Recent advances on follicular lymphoma (FL) have led to significant changes in disease management. Healthcare providers (HCPs) and their patients face multiple challenges, from treatment initiation, to navigating, selecting and sequencing treatment options while balancing the efficacy and toxicities of available options in the first‐line setting and beyond. To address these needs, in partnership with the Leukemia & Lymphoma Society, we created and measured the impact of continuing medical education (CME) to HCPs and healthcare education directed to patients.

METHODS: A 1-hour online video-based CME activity for HCPs and 1-hour healthcare education activity for patients were created in 2018 to address identified practice and knowledge needs among HCPs, and knowledge, communication and self-efficacy behaviors among patients. Each activity consisted of slides, polling and live questions, and were broadcast live and on-demand for 6 months at for HCPs, and, and Facebook Video for patients. Test questions were administered at 3 time points (pre-, immediate post-, and 2 mos. post-activity). Data from these test questions, responses to live polling questions, and learner-submitted questions during live Q&A were analyzed to determine engagement, lessons learned and continuing education gaps.

RESULTS: As of July 2019, 655 HCPs and 12,198 patients took part in the activities. HCPs reported the activity had a positive impact on patient clinical outcomes (58%) and clinical experience (60%). Significant gains in knowledge/competence were observed in 4 of 8 comparisons (avg. pre-post gain 40.75%, avg. Cohen’s d effect size .789) on: immunotherapy, clinical trial data, treatment initiation, and disease progression with immunochemotherapy. With patient learners, 47% reported improved communication with their healthcare providers, 49% increased feeling in control of health care decisions, 40% improved their health-related behaviors, and 17% improved engagement in shared decision making. Significant gains in knowledge were observed in 3 of 8 comparisons (avg. pre-post gain 19.25%, avg. Cohen’s d effect size .298) on: treatment for untreated advanced-stage FL, and steps to improve patient care.

CONCLUSIONS: CME and patient education can yield gains in clinical practice behaviors, patient healthcare communication and self-efficacy, and treatment knowledge of FL. Together, aligned education directed to HCPs and patients can improve the ability to provide individualized treatment for patients. Continuing education for HCPs is advised on prognostic factors and initial treatment choice for untreated advanced stage FL, post-induction and management strategies for early relapse, emerging agents for FL, and balancing patient desire for therapy where observation is still viable option. For patients, further education is recommended on elements of disease monitoring, pharmacologic and non-pharmacologic treatment options for FL, side effects of therapy, strategies to address relapse, benefits of shared decision-making, and access to specialists and support groups.